Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT03439839 · COMPLETED
Trial details
- NCT number
- NCT03439839
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2020-04-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.